ARCHIVES

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Milken Calls For Renewed War On Cancer, $20 Billion A Year International Effort

November 24, 1995

NCI Workshop Not “A Formality,” Baines Responds To Kopans

November 19, 1993

House Appropriations Boosts NIH By $1 Billion In Draft Budget That Cuts Other HHS Programs

September 30, 2011

NCI-Approved Clinical Trials

February 24, 2006

LAK –IL-2 Studies Continue, Moertel Editorial Blasted

March 13, 1987

Upton Finds Work For Former Division, Program Directors

September 14, 1979